Market Overview

UPDATE: Piper Jaffray Raises Price Target on Thoratec to $33

According to Piper Jaffray, Thoratec (NASDAQ: THOR) price target is raised to $33.

Piper Jaffray said that it is incrementally more positive on Neutral-rated THOR after attending the HFSA convention in Boston. “We are increasing our price target to $33/share to reflect current Medtech multiples and our updated estimates.”

Thoratec closed yesterday at $30.43.

Posted-In: Piper JaffrayAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (THOR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free

Benzinga Professional